Celldex Therapeutics, Inc. Profile Avatar - Palmy Investing

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflamma…

Biotechnology
US, Hampton [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Celldex Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CLDX's Analysis
CIK: 744218 CUSIP: 15117B202 ISIN: US15117B2025 LEI: - UEI: -
Secondary Listings
CLDX has no secondary listings inside our databases.